CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRISPR Therapeutics AG (CRSP)
Today's Latest Price: $91.82 USD
Updated Oct 30 4:00pm
Add CRSP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CRSP Stock Summary
- With a price/sales ratio of 87.99, CRISPR Therapeutics AG has a higher such ratio than 97.03% of stocks in our set.
- Over the past twelve months, CRSP has reported earnings growth of 1,884.94%, putting it ahead of 99.08% of US stocks in our set.
- Revenue growth over the past 12 months for CRISPR Therapeutics AG comes in at -63.63%, a number that bests just 2.63% of the US stocks we're tracking.
- Stocks that are quantitatively similar to CRSP, based on their financial statements, market capitalization, and price volatility, are ZYME, FATE, NKTR, ARVN, and CLLS.
- CRSP's SEC filings can be seen here. And to visit CRISPR Therapeutics AG's official web site, go to www.crisprtx.com.
CRSP Stock Price Chart Interactive Chart >
CRSP Price/Volume Stats
| Current price | $91.82 | 52-week high | $111.90 |
| Prev. close | $96.35 | 52-week low | $32.30 |
| Day low | $90.01 | Volume | 1,056,100 |
| Day high | $96.68 | Avg. volume | 1,023,119 |
| 50-day MA | $90.47 | Dividend yield | N/A |
| 200-day MA | $70.04 | Market Cap | 6.44B |
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
Loading social stream, please wait...